Literature DB >> 15763132

Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.

J N Mason1, H Farmer, I D Tomlinson, J W Schwartz, V Savchenko, L J DeFelice, S J Rosenthal, R D Blakely.   

Abstract

Pre-synaptic norepinephrine (NE) and dopamine (DA) transporters (NET and DAT) terminate catecholamine synaptic transmission through reuptake of released neurotransmitter. Recent studies reveal that NET and DAT are tightly regulated by receptor and second messenger-linked signaling pathways. Common approaches for studying these transporters involve use of radiolabeled substrates or antagonists, methods possessing limited spatial resolution and that bear limited opportunities for repeated monitoring of living preparations. To circumvent these issues, we have explored two novel assay platforms that permit temporally resolved quantitation of transport activity and transporter protein localization. To monitor the binding and transport function of NET and DAT in real-time, we have investigated the uptake of the fluorescent organic compound 4-(4-diethylaminostyryl)-N-methylpyridinium iodide (ASP+). We have extended our previous single cell level application of this substrate to monitor transport activity via high-throughput assay platforms. Compared to radiotracer uptake methods, acquisition of ASP+ fluorescence is non-isotopic and allows for continuous, repeated transport measurements on both transfected and native preparations. Secondly, we have extended our application of small-molecule-conjugated fluorescent CdSe/ZnS nanocrystals, or quantum dots (Qdots), to utilize antibody and peptide ligands that can identify surface expressed transporters, receptors and other membrane proteins in living cell systems. Unlike typical organic fluorophores, Qdots are highly resistant to bleaching and can be conjugated to multiple ligands. They can also be illuminated by conventional light sources, yet produce narrow, gaussian emission spectra compatible with multiple target visualization (multiplexing). Together, these approaches offer novel opportunities to investigate changes in transporter function and distribution in real-time with superior spatial and temporal resolution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15763132     DOI: 10.1016/j.jneumeth.2004.09.028

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  36 in total

1.  Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+.

Authors:  Murat Oz; Therissa Libby; Bronwyn Kivell; Vanaja Jaligam; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

2.  Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.

Authors:  Erik Rytting; Jordan Bryan; Marylee Southard; Kenneth L Audus
Journal:  Biochem Pharmacol       Date:  2006-12-01       Impact factor: 5.858

3.  Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content.

Authors:  Erica A Wehrwein; Lindsay M Parker; Anna A Wright; John M Spitsbergen; Martin Novotny; Dagmar Babankova; Greg M Swain; Beth A Habecker; David L Kreulen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-18       Impact factor: 3.619

4.  Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway.

Authors:  Gabor Horvath; Nathalie Schmid; Miryam A Fragoso; Andreas Schmid; Gregory E Conner; Matthias Salathe; Adam Wanner
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-17       Impact factor: 6.914

5.  Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.

Authors:  David J Wagner; Haichuan Duan; Alenka Chapron; Richard W Lee; Joanne Wang
Journal:  Xenobiotica       Date:  2017-03-02       Impact factor: 1.908

6.  Binding of muscimol-conjugated quantum dots to GABAC receptors.

Authors:  Hélène A Gussin; Ian D Tomlinson; Deborah M Little; Michael R Warnement; Haohua Qian; Sandra J Rosenthal; David R Pepperberg
Journal:  J Am Chem Soc       Date:  2006-12-13       Impact factor: 15.419

7.  Characterization of diadzein-hemoglobin binding using optical spectroscopy and molecular dynamics simulations.

Authors:  Bidisha Sengupta; Sandipan Chakraborty; Maurice Crawford; Jasmine M Taylor; Laura E Blackmon; Pradip K Biswas; Wolfgang H Kramer
Journal:  Int J Biol Macromol       Date:  2012-05-16       Impact factor: 6.953

8.  The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.

Authors:  Murat Oz; Vanaja Jaligam; Sehamuddin Galadari; George Petroianu; Yaroslav M Shuba; Toni S Shippenberg
Journal:  J Neurochem       Date:  2009-12-24       Impact factor: 5.372

9.  Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.

Authors:  Haichuan Duan; Tao Hu; Robert S Foti; Yongmei Pan; Peter W Swaan; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2015-08-18       Impact factor: 3.922

10.  Targeting the human serotonin transporter (hSERT) with quantum dots.

Authors:  I D Tomlinson; Jerry Chang; Hideki Iwamoto; Louis J De Felice; Randy D Blakely; Sandra J Rosenthal
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2008-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.